Company: BDRX
Filing Date: 2025-11-17
Form Type: F-1
Source: 0001214659-25-016821
Chunk: 161

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-17
Form: F-1
Chunk 161
---
 and Enforcement of Foreign Arbitral Awards).

<div align='center'>EXPENSES OF THE OFFERING</div>

The following table sets
forth the expenses payable by us in connection with the sale and distribution of the securities being registered hereby. All amounts shown,
other than the SEC registration fee and FINRA filing fee, are estimates:

| SEC registration fee    | $ | 14,231 |
| FINRA filing fee        |   |  3,088 |
| Printing expenses       |   |  5,000 |
| Accounting services     |   |      * |
| Legal fees and expenses |   |      * |
| Miscellaneous           |   |      * |
| Total                   | $ |      * |

* To be updated by amendment

| 93 |

<div align='center'>Biodexa Pharmaceuticals PLC

Up to 3,377,110 Units, Each Unit Consisting of One American Depositary Share

and One Series L Warrant to Purchase One American Depositary Share

or

Up to 3,377,110 Pre-Funded Units, Each Pre-Funded Unit Consisting of One Pre-Funded Warrant to Purchase One American Depositary Share

and One Series L Warrant to Purchase One American Depositary Share

Up to 3,377,110 American Depositary Shares Representing 337,711,000,000 Ordinary Shares

Up to 3,377,110 American Depositary Shares Representing 337,711,000,000 Ordinary Shares Underlying the Pre-Funded Warrants

Up to 50,656,650 American Depositary Shares Representing 5,065,665,000,000 Ordinary Shares Underlying the Series L Warrants (which contain a “zero cash exercise price” option)

Up to 2,532,825 American Depositary Shares Representing 253,282,500,000 Underlying the Placement Agent Warrants (which contain a “zero cash exercise price” option)

PRELIMINARY PROSPECTUS

Sole Placement Agent

MAXIM GROUP LLC

, 2025</div>

| 94 |

<div align='center'>PART II

INFORMATION NOT REQUIRED IN PROSPECTUS</div>

| Item 6. | Indemnification of Directors and Officers. |

The Registrant’s articles
of association provide that, subject to the Companies Act, every person who is or was at any time a director, alternate director, or former
director of the Registrant or of any of its subsidiaries